Imagene and GBMHM optimize molecular analyses

Evry, France, 15th January, 2014

Imagene and the Group of Molecular Biologists for Hematological Malignancies (GBMHM) have signed a partnership agreement. The goal is to use Imagene’s technology to produce, store and distribute the standards needed for molecular analysis of patients with leukemia and other blood cancers. 

Download the press release (in French)